Dow Down 0.92% Nasdaq Down 0.83%

Alexion Pharmaceuticals, Inc. (ALXN)

-NasdaqGS
173.27 Down 1.21(0.69%) Oct 22, 4:00PM EDT
|After Hours : 172.98 Down 0.29 (0.17%) Oct 22, 7:57PM EDT
Prev Close:174.48
Open:175.00
Bid:157.00 x 100
Ask:178.50 x 400
1y Target Est:198.57
Beta:1.07
Next Earnings Date:23-Oct-14ALXN Earnings announcement
Day's Range:170.22 - 175.09
52wk Range:110.67 - 185.43
Volume:1,420,191
Avg Vol (3m):1,179,410
Market Cap:34.28B
P/E (ttm):86.85
EPS (ttm):2.00
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for ALXN

Comparison

Symbol% ChgMkt Cap
ALXNDown 0.69%34.28B
AMGNDown 0.31%109.11B
BAXDown 0.41%37.03B

Key Statistics

Forward P/E (1 yr):30.24
P/S (ttm):17.96
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :5.01
Quarterly EPS Est (Sep-14) :1.16
Mean Recommendation*:1.9
PEG Ratio (5 yr expected):1.13

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Alexion Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes life-transforming therapeutic products. It offers Soliris (eculizumab), a therapeutic product to treat paroxysmal nocturnal hemoglobinuria (PNH), a genetic blo... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback